Phase
Condition
Vascular Diseases
Heart Valve Disease
Treatment
Transcatheter Tricuspid Valve Replacement
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult patients
Tricuspid regurgitation grade 3 (severe) on a scale of 0 (none) to 5 (torrential)
Institutional Heart Team evaluates patient as being at increased operative risk
Exclusion
Exclusion Criteria:
Patient in need of emergent intervention
Patient who is hemodynamically unstable
Anatomical contraindications for implantation with study device
Patient who is currently participating in another clinical investigation where theprimary endpoint was not reached yet
Study Design
Study Description
Connect with a study center
Algemeen Stedelijk Ziekenhuis
Aalst, 9300
BelgiumActive - Recruiting
ZNA Middelheim
Antwerpen,
BelgiumActive - Recruiting
Cliniques Universitaires Saint-Luc UCL
Bruxelles,
BelgiumSite Not Available
UZ Brussel
Bruxelles, 1090
BelgiumSite Not Available
Centre hospitalier universitaire CHU de Liège
Liège,
BelgiumSite Not Available
AZ Delta
Roeselare, 8800
BelgiumActive - Recruiting
University Medical Center of the Johannes Gutenberg University Mainz
Mainz, 55131
GermanySite Not Available
Ludwig Maximilian University Hospital
Munich, 81377
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.